Ivermectin vs. Merck's new antiviral, Molnupiravir -- Health & Wellness -- Sott.net
In the video above retired nurse lecturer John Campbell, Ph.D., reports on a comparative analysis of molnurpirivir and ivermectin published in the Austin Journal of Pharmacology and Therapeutics.1 The first is Merck's new antiviral drug and the...